References
- Ahn DH, Rah H, Choi YK, et al (2013). Association of the miR- 146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric cancer risk and survival in the Korean population. Mol Carcinog, 52, 39-51.
- Ambros V (2004). The functions of animal microRNAs. Nature, 431, 350-5. https://doi.org/10.1038/nature02871
- Bartel DP (2009). MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-33. https://doi.org/10.1016/j.cell.2009.01.002
- Calin GA, Croce CM (2006). MicroRNA signatures in human cancers. Nat Rev Cancer, 6, 857-66. https://doi.org/10.1038/nrc1997
- DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. https://doi.org/10.1016/0197-2456(86)90046-2
- Dikeakos P, Theodoropoulos G, Rizos S, et al (2014). Association of the miR-146aC>G, miR-149T>C, and miR- 196a2T>C polymorphisms with gastric cancer risk and survival in the Greek population. Mol Biol Rep, 41, 1075-80. https://doi.org/10.1007/s11033-013-2953-0
- Ebert MS, Sharp PA (2012). Roles for microRNAs in conferring robustness to biological processes. Cell, 149, 515-24. https://doi.org/10.1016/j.cell.2012.04.005
- Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
- Esquela-Kerscher A, Slack FJ (2006). Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer, 6, 259-69. https://doi.org/10.1038/nrc1840
- Fabian MR, Sonenberg N (2012). The mechanics of miRNAmediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol, 19, 586-93. https://doi.org/10.1038/nsmb.2296
- Furuta M, Kozaki KI, Tanaka S, et al (2010). miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis, 31, 766-76. https://doi.org/10.1093/carcin/bgp250
- Gao LB, Bai P, Pan XM, et al (2011). The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res Treat, 125, 571-4. https://doi.org/10.1007/s10549-010-0993-x
- Hatley ME, Patrick DM, Garcia MR, et al (2010). Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell, 18, 282-93. https://doi.org/10.1016/j.ccr.2010.08.013
- He L, Hannon GJ (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet, 5, 522-31. https://doi.org/10.1038/nrg1379
- Hu CB, Li QL, Hu JF, et al (2014). miR-124 inhibits growth and invasion of gastric cancer by targeting ROCK1. Asian Pac J Cancer Prev, 15, 6543-6. https://doi.org/10.7314/APJCP.2014.15.16.6543
- Jansson MD, Lund AH (2012). MicroRNA and cancer. Mol Oncol, 6, 590-610. https://doi.org/10.1016/j.molonc.2012.09.006
- Ji T, Zheng ZG, Wang FM, et al (2014). Differential microRNA expression by Solexa sequencing in the sera of ovarian cancer patients. Asian Pac J Cancer Prev, 15, 1739-43. https://doi.org/10.7314/APJCP.2014.15.4.1739
- Jinushi T, Shibayama Y, Kinoshita I, et al (2014). Low expression levels of microRNA-124-5p correlated with poor prognosis in colorectal cancer via targeting of SMC4. Cancer Med, 3, 1544-52. https://doi.org/10.1002/cam4.309
- Kong YW, Ferland-McCollough D, Jackson TJ, et al (2012). microRNAs in cancer management. Lancet Oncol, 13, 249-58. https://doi.org/10.1016/S1470-2045(12)70073-6
- Krol J, Loedige I, Filipowicz W (2010). The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet, 11, 597-610. https://doi.org/10.1038/nrg2843
- Kutanzi KR, Yurchenko OV, Beland FA, et al (2011). MicroRNA-mediated drug resistance in breast cancer. Clin Epigenetics, 2, 171-85. https://doi.org/10.1007/s13148-011-0040-8
- Li L, Luo J, Wang B, et al (2013). Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer. Mol Cancer, 12, 163. https://doi.org/10.1186/1476-4598-12-163
- Li W, Zang W, Liu P, et al (2014). MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer. Tumour Biol, 35, 10897-904. https://doi.org/10.1007/s13277-014-2402-2
- Lian H, Wang L, Zhang J (2012). Increased risk of breast cancer associated with CC genotype of Has-miR-146a Rs2910164 polymorphism in Europeans. PLoS ONE, 7, 31615. https://doi.org/10.1371/journal.pone.0031615
- Link A, Kupcinskas J, Wex T, et al (2012). Macro-role of microRNA in gastric cancer. Dig Dis, 30, 255-67. https://doi.org/10.1159/000336919
- Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
- Pasquinelli AE (2012). MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet, 13, 271-82. https://doi.org/10.1038/nrg3162
- Peng XH, Huang HR, Lu J, et al (2014). MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma. Mol Cancer, 13, 186. https://doi.org/10.1186/1476-4598-13-186
- Pritchard CC, Cheng HH, Tewari M (2012). MicroRNA profiling: approaches and considerations. Nat Rev Genet, 13, 358-69.
- Ruan K, Fang X, Ouyang G (2009). MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett, 285, 116-26. https://doi.org/10.1016/j.canlet.2009.04.031
- Suarez Y, Sessa WC (2009). MicroRNAs as novel regulators of angiogenesis. Circ Res, 104, 442-54. https://doi.org/10.1161/CIRCRESAHA.108.191270
- Tong N, Xu B, Shi D, et al (2014). Hsa-miR-196a2 polymorphism increases the risk of acute lymphoblastic leukemia in Chinese children. Mutat Res Fundam Mol Mech Mutagen, 759, 16-21. https://doi.org/10.1016/j.mrfmmm.2013.11.004
- Wan HY, Li QQ, Zhang Y, et al (2014). MiR-124 represses vasculogenic mimicry and cell motility by targeting amotL1 in cervical cancer cells. Cancer Lett, 355, 148-58. https://doi.org/10.1016/j.canlet.2014.09.005
- Wang J, Bi J, Liu X, et al (2012). Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-analysis of 19 casecontrol studies. Mol Biol Rep, 39, 4571-9. https://doi.org/10.1007/s11033-011-1247-7
- Woolf B (1955). On estimating the relation between blood group and disease. Ann Hum Genet, 19, 251-3. https://doi.org/10.1111/j.1469-1809.1955.tb01348.x
- Wu H, Zhang J (2014). miR-124 rs531564 polymorphism influences genetic susceptibility to cervical cancer. Int J Clin Exp Med, 7, 5847-51.
- Xiong X, Cheng J, Liu X, et al (2014). [Correlation analysis between miR-124 rs531564 polymorphisms and susceptibility to cervical cancer]. Nan Fang Yi Ke Da Xue Xue Bao, 34, 210-3.
- Yin J, Wang X, Zheng L, et al (2013). Hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A polymorphisms are associated with the risk of esophageal cancer in a Chinese population. PLoS ONE, 8, 80570. https://doi.org/10.1371/journal.pone.0080570
- Zhang J, Huang X, Xiao J, et al (2014a). Pri-miR-124 rs531564 and pri-miR-34b/c rs4938723 polymorphisms are associated with decreased risk of esophageal squamous cell carcinoma in Chinese populations. PLoS ONE, 9, 100055. https://doi.org/10.1371/journal.pone.0100055
- Zhang T, Wang J, Zhai X, et al (2014b). MiR-124 retards bladder cancer growth by directly targeting CDK4. Acta Biochim Biophys Sin (Shanghai), 46, 1072-9. https://doi.org/10.1093/abbs/gmu105
Cited by
- A meta-analysis: Is there any association between MiR-608 rs4919510 polymorphism and breast cancer risks? vol.12, pp.8, 2017, https://doi.org/10.1371/journal.pone.0183012
- Polymorphisms in MIR122, MIR196A2, and MIR124A Genes are Associated with Clinical Phenotypes in Inflammatory Bowel Diseases vol.21, pp.1, 2017, https://doi.org/10.1007/s40291-016-0240-1
- Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival vol.6, pp.2, 2017, https://doi.org/10.1002/cam4.989
- Involving the microRNA Targetome in Esophageal-Cancer Development and Behavior vol.10, pp.10, 2018, https://doi.org/10.3390/cancers10100381